Targeting connexin 43 with α–connexin carboxyl-terminal (ACT1) peptide enhances the activity of the targeted inhibitors, tamoxifen and lapatinib, in breast cancer: clinical implica...

por Grek, Christina L, Rhett, Joshua Matthew, Bruce, Jaclynn S, Abt, Melissa A, Ghatnekar, Gautam S, Yeh, Elizabeth S
Publicado 2015